Tim Considine

Interim Head of Corporate Development at Forcyte Biotechnologies

About

Links

Previous companies

Recursion Pharmaceuticals logo
Nuritas logo
Stoel Rives LLP logo
Known Medicine logo
Q Therapeutics logo

Org chart

Peers

Ivan Pushkarsky

President

Mike Bishop

Interim Director, Medicinal Chemistry

Timeline

  • Interim Head of Corporate Development

    March, 2022 - present

View in org chart